scispace - formally typeset
Search or ask a question
Book ChapterDOI

Chapter 13 Rauwolfia Alkaloids with Special Reference to the Chemistry of Reserpine

01 Jan 1965-Vol. 8, pp 287-334
TL;DR: This chapter describes Rauwolfia alkaloids with special reference to the chemistry of reserpine, which has become important therapeutic agents, both as sedatives and antihypertensives.
Abstract: Publisher Summary This chapter describes Rauwolfia alkaloids with special reference to the chemistry of reserpine. Rauwolfia products have become important therapeutic agents, both as sedatives and antihypertensives. Although their production and use have fallen off since the peak years of 1955 and 1956, it is estimated that their total sales a t the consumers' level in 1961 still amounted to $100 million in the United States alone. Since 1952, the year reserpine was first isolated, several thousand articles have been published on the isolation, chemistry, pharmacology, and clinical aspects of reserpine and other Rauwolfia alkaloids, and today these investigations are still being pursued. Botanists estimate the number of identified Rauwolfia species to be about 50, of which R. serpentina, R. canescens, R. vomitoria, and R. ligustrina have been investigated in detail. Only the first three species are important from the standpoint of supplies of therapeutically useful alkaloids; the last species is not especially rich in reserpine, but has nevertheless been investigated in great detail. The Indian plant, R. serpentina, has lost much of its importance (except for local production), as its reserpine content (0.1%) is only about half that of R. vomitoria, which is at present the most important species. It grows so plentifully in Central Africa, especially in the Congo, that cultivation is not necessary. It is considerably taller than R. serpentina, and procedures have been developed by Congolese collectors by which the smaller side roots may be cut periodically without loss of the tree.
Citations
More filters
Journal ArticleDOI
TL;DR: A functionalized hydrindanone enables a divergent strategy that builds on existing precedent to address this long-standing challenge of complete control in setting the C(3) stereocentre at a late stage of the yohimbinoid skeleton.
Abstract: The yohimbinoid alkaloids continue to receive considerable attention from the synthetic community because of their interesting chemical structures and varied biological activity. Although there are several elegant syntheses of certain members of this group of alkaloids, a truly unified approach has yet to be developed. In short, general approaches to this compound class are hampered by a lack of complete control in setting the C(3) stereocentre at a late stage. Herein, we report that a functionalized hydrindanone enables a divergent strategy that builds on existing precedent to address this long-standing challenge. Utilizing an aminonitrile intermediate, the stereochemistry at C(3) of the yohimbinoid skeleton can be controlled effectively in a Pictet-Spengler reaction. We applied this approach to the first total syntheses of the C(3) epimeric natural products venenatine and alstovenine.

46 citations

Journal ArticleDOI
TL;DR: A new UHPLC-UV method has been developed for the simultaneous analysis of seven alkaloids from the root samples of Rauwolfia serpentina (L.) Benth and the results indicated that commercial products are of variable quality.
Abstract: A new UHPLC-UV method has been developed for the simultaneous analysis of seven alkaloids [ajmaline (1), yohimbine (2), corynanthine (3), ajmalicine (4), serpentine (5), serpentinine (6), and reserpine (7)] from the root samples of Rauwolfia serpentina (L.) Benth. ex Kurz. The chromatographic separation was achieved using a reversed phase C18 column with a mobile phase of water and acetonitrile, both containing 0.05 % formic acid. The seven compounds were completely separated within 8 min at a flow rate of 0.2 mL/min with a 2-μL injection volume. The method is validated for linearity, accuracy, repeatability, limits of detection (LOD), and limits of quantification (LOQ). Seven plant samples and 21 dietary supplements claiming to contain Rauwolfia roots were analyzed and content of total alkaloids (1–7) varied, namely, 1.57–12.1 mg/g dry plant material and 0.0–4.5 mg/day, respectively. The results indicated that commercial products are of variable quality. The developed analytical method is simple, economic, fast, and suitable for quality control analysis of Rauwolfia samples and commercial products. The UHPLC-QToF-mass spectrometry with electrospray ionization (ESI) interface method is described for the confirmation and characterization of alkaloids from plant samples. This method involved the detection of [M + H]+ or M+ ions in the positive mode.

29 citations

Book ChapterDOI
01 Jan 1977
TL;DR: Preparations derived from species of Rauwolfia, a plant genus belonging to the Apocynaceae family, have been used for the treatment of a great variety of diseases in the folk medicine of the regions in which they are found.
Abstract: Preparations derived from species of Rauwolfia, a plant genus belonging to the Apocynaceae family, have been used for the treatment of a great variety of diseases in the folk medicine of the regions in which they are found. The species R. serpentina is a climbing or twining shrub occurring in the Indian sub-continent and S.E. Asia. The root of this plant has been used since ancient times in both India and the Malay peninsula as an antidote to the stings and bites of insects and poisonous reptiles. It has also been used to reduce fever, as a stimulant to uterine contractions, for insomnia, and particularly for the treatment of insanity.

25 citations

Journal ArticleDOI
TL;DR: In the recent excursion into applications of synthetic organic chemistry to neuroscience, avoiding the more-traveled paths was richly rewarding, and the unexpected often led to new revelations and insights.
Abstract: Diverse structural types of natural products and their mimics have served as targets of opportunity in our laboratory to inspire the discovery and development of new methods and strategies to assemble polyfunctional and polycyclic molecular architectures. Furthermore, our efforts toward identifying novel compounds having useful biological properties led to the creation of new targets, many of which posed synthetic challenges that required the invention of new methodology. In this Perspective, selected examples of how we have exploited a diverse range of natural products and their mimics to create, explore, and solve a variety of problems in chemistry and biology will be discussed. The journey was not without its twists and turns, but the unexpected often led to new revelations and insights. Indeed, in our recent excursion into applications of synthetic organic chemistry to neuroscience, avoiding the more-traveled paths was richly rewarding.

19 citations

References
More filters
Journal ArticleDOI
TL;DR: In this article, a trans-Chinolizidin-Ringsystem is vorliegt, wenn, durch Konstitution and Konfiguration eines Molekuls bedingt, ein cis-chinolizerin-ringsystem vor liegt.
Abstract: Es wird eine charakteristische Bandengruppe im IR-Spektrum beschrieben, die in Piperidinderivaten nur dann auftritt, wenn mindestens zwei nachbarstandige axiale CH-Bindungen in trans-Stellung zum einsamen Elektronenpaar am Stickstoff stehen. Dies ist z. B. in trans-Chinolizidin-Ringen der Fall, aber nicht, wenn, durch Konstitution und Konfiguration eines Molekuls bedingt, ein cis-Chinolizidin-Ringsystem vorliegt. Durch Synthese deuterierter Basen last sich die fragliche Bandengruppe eindeutig zuordnen.

460 citations

Journal ArticleDOI
Robert B. Woodward1, F. E. Bader1, H. Bickel1, A. J. Frey1, R. W. Kierstead1 

228 citations

Journal Article
TL;DR: It is concluded that Ro 1-9569 and reserpine compete for the same receptor sites, and the sedative effect of the drug seems to be related to the change in brain serotonin rather than norepinephrine.
Abstract: A method is described for the estimation of Ro 1-9569 (tetrabenazine), a non-indole synthetic derivative of benzoquinolizine, in biological tissues. After intravenous injection in the rabbit, Ro 1-9569 is rapidly and almost completely metabolized. The duration of action of the drug is limited to the time that appreciable amounts of the compound remain in the body. The drug has a selective action on brain serotonin anti norepinephrine, releasing little or none of these amines peripherally. Consequently, the drug does not elicit diarrhea, which occurs with the release of serotonin in the intestines, or hypotemision associated with the depletion of norepinephrine from sympathetic nerve endings. Ro 1-9569 has a greater effect on brain norepinephrine than on brain serotonin. However, the sedative effect of the drug seems to be related to the change in brain serotonin rather than norepinephrine. Animals given Ho 1-9569 immediately before reserpine respond as though they received only Ro 1-9569. It is concluded that Ro 1-9569 and reserpine compete for the same receptor sites.

195 citations